Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 795-800

  Williams, Kerstin J ^a   Chung, Gavin A C ^b   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; NORFLOXACIN;

ANIMAL CELL; ANTIBIOTIC THERAPY; ARTICLE; BIOACCUMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DIFFUSION; FLUORESCENCE; METHODOLOGY; MYCOBACTERIOSIS; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PH; PRIORITY JOURNAL;

EID: 0031968179     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.795     Document Type: Article

References (42)

1. Alangaden, G. J., E. K. Manavathu, S. B. Vakulenko, N. M. Zvonok, and S. A. Lerner. 1995. Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrob. Agents Chemother. 39:1700-1703.
2. Asuquo, A. E., and L. J. V. Piddock. 1993. Accumulation and killing of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 31:865-880.
3. Berlin, O. G. W., L. S. Young, and D. A. Bruckner. 1987. In vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis. J. Antimicrob. Chemother. 19:611-615.
4. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64:26-63.
5. Cambau, E., W. Sougakoff, M. Besson, C. Truffot-Pernot, J. Grosset, and V. Jarlier. 1994. Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. J. Infect. Dis. 170:479-483.
6. Canton, E., J. Peman, M. T. Jimenez, M. S. Ramon, and M. Gobernado. 1992. In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrob. Agents Chemother. 36:558-565.
7. Chambers, H. F., D. Moreau, D. Yajko, C. Miick, C. Wagner, C. Hackbarth, S. Kocagoz, E. Rosenberg, W. K. Hadley, and H. Nikaido. 1995. Can penicillins and other β-lactams be used to treat tuberculosis? Antimicrob. Agents Chemother. 39:2620-2624.
8. Chung, G. A. C., Z. Aktar, S. Jackson, and K. Duncan. 1995. High-through-put screening for detecting antimycobacterial agents. Antimicrob. Agents Chemother. 39:2235-2238.
9. Cohen, S. P., D. C. Hooper, J. S. Wolfson, K. S. Souza, L. M. McMurray, and S. B. Levy. 1988. Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrob. Agents Chemother. 32:1187-1191.
10. Corti, S., J. Chevalier, and A. Cremieux. 1995. Intracellular accumulation of norfloxacin in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 39:2466-2471.
11. Furet, Y. X., J. Deshusses, and J. C. Pechere. 1992. Transport of perfloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:2506-2511.
12. Hooper, D. C., and J. S. Wolfson. 1991. Mode of action of the new quinolones: new data. Eur. J. Clin. Microbiol. Infect. Dis. 10:223-231.
13. Hoshino, K., A. Kitamura, I. Morrissey, K. Sato, J. Kato, and H. Ikeda. 1994. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob. Agents Chemother. 38:2623-2627.
14. Jarlier, V., and H. Nikaido. 1990. Permeability barrier to hydrophilic solutes in Mycobacterium chelonae. J. Bacteriol. 172:1418-1423.
15. Jarlier, V., and H. Nikaido. 1994. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 123:11-18.
16. Ji, B., C. Truffot-Pernot, and J. Grosset. 1991. In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis. Tubercle 72: 181-186.
17. Kocagoz, T., C. J. Hackbarth, I. Unsal, E. Y. Rosenberg, H. Nikaido, and H. F. Chambers. 1996. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 40:1768-1774.
18. Lalande, V., C. Truffot-Pernot, A. Paccaly-Moulin, J. H. Grosset, and B. Ji. 1993. Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice. Antimicrob. Agents Chemother. 37:407-413.
19. Li, X. Z., D. Ma, D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to β-lactam resistance. Antimicrob. Agents Chemother. 38:1732-1742.
20. Liu, J., H. E. Takiff, and H. Nikaido. 1996. Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump. J. Bacteriol. 178:3791-3795.
21. Lopez-Hernandez, I., L. Martinez-Martinez, A. Pascual, I. I. Garcia, and E. J. Perea. 1997. Accumulation of fluoroquinolones in Acinetobacter baumannii. J. Clin. Microbiol. Infect. 3:176.
22. McCaffrey, C., A. Bertasso, J. Pace, and N. H. Georgopapadakou. 1992. Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Antimicrob. Agents Chemother. 36:1601-1605.
23. Mitchison, D. A. 1992. The Garrod Lecture. Understanding the chemotherapy of tuberculosis. J. Antimicrob. Chemother. 29:477-493.
24. Mortimer, P. G. S., and L. J. V. Piddock. 1991. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J. Antimicrob. Chemother. 28:639-653.
25. Munoz, R., and A. G. Delacampa. 1996. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase-A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
26. Pan, X. S., and L. M. Fisher. 1997. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob. Agents Chemother. 41:471-474.
27. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.
28. Piddock, L. J. V. 1991. Mechanism of quinolone uptake into bacterial cells. J. Antimicrob. Chemother. 27:399-403.
29. Piddock, L. J. V. 1994. New quinolones and gram-positive bacteria. Antimicrob. Agents Chemother. 38:163-169.
30. Piddock, L. J. V. 1995. Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994. Drugs 49:29-35.
31. Rastogi, N., V. Labrousse, and A. Bryskier. 1995. Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages. Antimicrob. Agents Chemother. 39:976-978.
32. Tomioka, H., H. Saito, and K. Sato. 1993. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin. Antimicrob. Agents Chemother. 37:1259-1263.
33. Trias, J., V. Jarlier, and R. Benz. 1992. Porins in the cell wall of mycobacteria. Science 258:1479-1481.
34. Trias, J., and R. Benz. 1993. Characterization of the channel formed by the mycobacterial porin in lipid bilayer membranes. J. Biol. Chem. 268:6234-6240.
35. Trias, J., and R. Benz. 1994. Permeability of the cell wall of Mycobacterium smegmatis. Mol. Microbiol. 14:283-290.
36. Ubukata, K., N. Itoh-Yamashita, and M. Konno. 1989. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 33:1535-1539.
37. Van Boxtel, R. M., R. S. Lambrecht, and M. T. Collins. 1990. Effects of colonial morphology and Tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis. Antimicrob. Agents Chemother. 34:2300-2303.
38. Vila, J., J. Ruiz, P. Goni, and M. T. J. Deanta. 1996. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:491-493.
39. Williams, K. J., and L. J. V. Piddock. 1996. gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong. J. Antimicrob. Chemother. 37:1032-1034.
40. Williams, K. J., and L. J. V. Piddock. Submitted for publication.
41. Williams, K. J., and L. J. V. Piddock. Unpublished data.
42. Young, L. S. 1993. The Garrod Lecture. Mycobacterial diseases in the 1990s. J. Antimicrob. Chemother. 32:179-194.